Corticotropin-Releasing Hormone Family of Peptides Regulates Intestinal Angiogenesis

Gastroenterology

Volumn 138, Issue 7, 2010, Pages

  Im, Eunok ^a   Rhee, Sang Hoon ^a   Park, Yong Seek ^b   Fiocchi, Claudio ^c   Taché, Yvette ^a   Pothoulakis, Charalabos ^a  

^a Digestive Disease Center   (United States)

^b Kyung Hee University Hospital   (South Korea)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

HIMECs; Inflammatory Bowel Disease; Neuropeptide; PI3K

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; DEXTRAN SULFATE; PROTEIN KINASE B; UROCORTIN III; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; EX VIVO STUDY; FEMALE; GENE DELETION; HISTOPATHOLOGY; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CELL; MALE; MICROVASCULATURE; MOUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL RATE; WEIGHT REDUCTION; WILD TYPE;

EID: 77952867821     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.02.055     Document Type: Article

References (40)

1. Jackson J.R., Seed M.P., Kircher C.H., et al. The codependence of angiogenesis and chronic inflammation. FASEB J 11 (1997) 457-465
2. Danese S., Sans M., de la Motte C., et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 130 (2006) 2060-2073
3. Kanazawa S., Tsunoda T., Onuma E., et al. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 96 (2001) 822-828
4. Danese S., Sans M., Spencer D.M., et al. Angiogenesis blockade as a new therapeutic approach to experimental colitis. Gut 56 (2007) 855-862
5. Vale W., Spiess J., Rivier C., et al. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 (1981) 1394-1397
6. Lewis K., Li C., Perrin M.H., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A 98 (2001) 7570-7575
7. Reyes T.M., Lewis K., Perrin M.H., et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A 98 (2001) 2843-2838
8. Hsu S.Y., and Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7 (2001) 605-611
9. Hillhouse E.W., and Grammatopoulos D.K. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev 27 (2006) 260-286
10. Muramatsu Y., Fukushima K., Iino K., et al. Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides 21 (2000) 1799-1809
11. Taché Y., and Bonaz B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 117 (2007) 33-40
12. Anton P.M., Gay J., Mykoniatis A., et al. Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation. Proc Natl Acad Sci U S A 101 (2004) 8503-8508
13. Kokkotou E., Torres D., Moss A.C., et al. Corticotropin-releasing hormone receptor 2-deficient mice have reduced intestinal inflammatory responses. J Immunol 177 (2006) 3355-3361
14. Million M., Tache Y., and Anton P. Susceptibility of Lewis and Fischer rats to stress-induced worsening of TNB-colitis: protective role of brain CRF. Am J Physiol 276 (1999) G1027-G1036
15. Bale T.L., Giordano F.J., Hickey R.P., et al. Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc Natl Acad Sci U S A 99 (2002) 7734-7739
16. Hao Z., Huang Y., Cleman J., et al. Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation. Proc Natl Acad Sci U S A 105 (2008) 3939-3944
17. Tezval H., Jurk S., Atschekzei F., et al. Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation. World J Urol (2009 May 13) [Epub ahead of print]
18. Tezval H., Jurk S., Atschekzei F., et al. The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways. Prostate 69 (2009) 443-448
19. Binion D.G., West G.A., Ina K., et al. Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. Gastroenterology 112 (1997) 1895-1907
20. Sartor R.B. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126 (2004) 1620-1633
21. Sandor Z., Deng X.M., Khomenko T., et al. Altered angiogenic balance in ulcerative colitis: a key to impaired healing?. Biochem Biophys Res Commun 350 (2006) 147-150
22. Tolstanova G., Khomenko T., Deng X., et al. Neutralizing anti-vascular endothelial growth factor (VEGF) antibody reduces severity of experimental ulcerative colitis in rats: direct evidence for the pathogenic role of VEGF. J Pharmacol Exp Ther 328 (2009) 749-757
23. Im E., and Kazlauskas A. Regulating angiogenesis at the level of PtdIns-4,5-P2. EMBO J 25 (2006) 2075-2082
24. Matsumoto T., and Claesson-Welsh L. VEGF receptor signal transduction. Sci. STKE 2001 (2001) RE21
25. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
26. Arbiser J.L., Karalis K., Viswanathan A., et al. Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin. J Invest Dermatol 113 (1999) 838-842
27. Irvine R. Nuclear lipid signaling. Sci STKE 2000 (2000) RE1
28. Plattner R., Irvin B.J., Guo S., et al. A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-gamma1. Nat Cell Biol 5 (2003) 309-319
29. la Fleur S.E., Wick E.C., Idumalla P.S., et al. Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum. Proc Natl Acad Sci U S A 102 (2005) 7647-7652
30. Wlk M., Wang C.C., Venihaki M., et al. Corticotropin-releasing hormone antagonists possess anti-inflammatory effects in the mouse ileum. Gastroenterology 123 (2002) 505-515
31. Saruta M., Takahashi K., Suzuki T., et al. Urocortin 1 in colonic mucosa in patients with ulcerative colitis. J Clin Endocrinol Metab 89 (2004) 5352-5361
32. Gay J., Kokkotou E., O'Brien M., et al. CRH-deficiency is associated with reduced local inflammation in a mouse model of experimental colitis. Endocrinology 149 (2008) 3403-3409
33. Chang J., Hoy J.J., Idumalla P.S., et al. Urocortin 2 expression in the rat gastrointestinal tract under basal conditions and in chemical colitis. Peptides 28 (2007) 1453-1460
34. Brun P., Mastrotto C., Beggiao E., et al. Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 288 (2005) G621-G629
35. Castagliuolo I., Morteau O., Keates A.C., et al. Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor. Br J Pharmacol 136 (2002) 271-279
36. Heidemann J., Ogawa H., Dwinell M.B., et al. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem 278 (2003) 8508-8515
37. Petreaca M.L., Yao M., Liu Y., et al. Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability. Mol Biol Cell 18 (2007) 5014-5023
38. Ganta V.C., Cromer W., Mills G.L., et al. Angiopoietin-2 in experimental colitis. Inflamm Bowel Dis (2009 Nov 9) [Epub ahead of print]
39. Kuhn M., Volker K., Schwarz K., et al. The natriuretic peptide/guanylyl cyclase--a system functions as a stress-responsive regulator of angiogenesis in mice. J Clin Invest 119 (2009) 2019-2030
40. Scaldaferri F., Vetrano S., Sans M., et al. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology 136 (2009) 585-595